Utilizamos cookies

Este sitio web utiliza cookies propias y de terceros para mantener la sesión, ofrecerle una mejor experiencia de usuario y obtener datos estadísticos de navegación de los usuarios. Para más información vea la Política de cookies.

Ver Investigador - - Prisma - Unidad de Bibliometría

Pilar Retamar Gentil

Profesora Contratada Doctora (Plaza Vinc.)
pretamar@us.es
Área de conocimiento: Medicina
Departamento: Medicina
Grupo: Sin grupo

Investiga en

Palabras clave
Líneas de investigación
Resumen
Tipo Año Título Fuente
Artículo2024 A comprehensive, predictive mortality score for patients with bloodstream infections (PROBAC): a prospective, multicentre cohort study. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2024 Antibiotic use and outcome in patients with negative blood cultures, a new target population for antimicrobial stewardship interventions: A prospective multicentre cohort (NO-BACT) JOURNAL OF INFECTION
Artículo2024 Association of microbiological factors with mortality in Escherichia coli bacteraemia presenting with sepsis/septic shock: A prospective cohort study. CLINICAL MICROBIOLOGY AND INFECTION
Artículo2024 Early antibiotic de-escalation in patients with severe infections due to bloodstream infection by Enterobacterales: a post-hoc analysis of a prospective multicentre cohort. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
Artículo2024 Efficacy and safety of a structured de-escalation from antipseudomonal β-lactams in bloodstream infections due to Enterobacterales (SIMPLIFY): an open-label, multicentre, randomised trial. LANCET INFECTIOUS DISEASES
Revisión2024 Universal Risk Factors for Mortality in Bloodstream Infections (UNIFORM): a systematic review and Delphi survey CLINICAL MICROBIOLOGY AND INFECTION
Artículo2024 Whole-genome characterisation of Escherichia coli isolates from patients with bacteraemia presenting with sepsis or septic shock in Spain: a multicentre cross-sectional study The Lancet Microbe
Capítulo2023 Antibioterapia al final de la vida en una unidad de Cuidados Paliativos: impacto en salud y percepción de los profesionales implicados Memorias académicas de La Real Academia de Medicina y Cirugía de Sevilla: año 2023
Artículo2023 Antimicrobial resistance in Gram-negative bacilli in Spain: an experts' view Revista Española de Quimioterapia
Artículo2023 Antimicrobial stewardship in hospitals: Expert recommendation guidance document for activities in specific populations, syndromes and other aspects (PROA-2) from SEIMC, SEFH, SEMPSPGS, SEMICYUC and SEIP Enfermedades infecciosas y microbiología clínica
Artículo2023 Effectiveness of fosfomycin trometamol as oral step-down therapy for bacteraemic urinary tract infections due to MDR Escherichia coli: a post hoc analysis of the FOREST randomized trial JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2023 Management of Patients with Suspected or Confirmed Antibiotic Allergy. Executive Summary of Guidance from the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), the Spanish Society of Allergy and Clinical Immunology (SEAIC), the Spanish Society of Hospital Pharmacy (SEFH) and the Spanish Society of Intensive Medicine and Coronary Care Units (SEMICYUC). JOURNAL OF INVESTIGATIONAL ALLERGOLOGY & CLINICAL IMMUNOLOGY
Artículo2023 Resumen ejecutivo de la Guía de práctica clínica de la Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC), la Sociedad Española de Alergología e Inmunología Clínica (SEAIC), la Sociedad Española de Farmacia Hospitalaria (SEFH) y la Sociedad Española de Medicina Intensiva Crítica y Unidades Coronarias (SEMICYUC) sobre el manejo de personas con alergia a antibióticos sospechada o confirmada Enfermedades infecciosas y microbiología clínica
Artículo2023 Ten Issues for Updating in Community-Acquired Pneumonia: An Expert Review. JOURNAL OF CLINICAL MEDICINE
Artículo2022 "Pseudomonas aeruginosa" Community-Onset Bloodstream Infections: Characterization, Diagnostic Predictors, and Predictive Score Development-Results from the PRO-BAC Cohort Antibiotics
Artículo2022 Autoantibodies against type I IFNs in patients with critical influenza pneumonia. JOURNAL OF EXPERIMENTAL MEDICINE
Revisión2022 Compatibility of prolonged infusion antibiotics during Y-site administration Nursing in Critical Care
Artículo2022 Effect of Combination Antibiotic Empirical Therapy on Mortality in Neutropenic Cancer Patients with Pseudomonas aeruginosa Pneumonia MICROORGANISMS
Artículo2022 Effectiveness of fosfomycin for the treatment of multidrug-resistant escherichia coli bacteremic urinary tract infections: a randomized clinical trial JAMA Network Open
Revisión2022 European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine) CLINICAL MICROBIOLOGY AND INFECTION
Artículo2022 Predictors of inappropriate antimicrobial prescription: Eight-year point prevalence surveys experience in a third level hospital in Spain FRONTIERS IN PHARMACOLOGY
Editorial2022 Pronosticando bacteriemias en Urgencias: cómo y porqué Enfermedades infecciosas y microbiología clínica
Artículo2022 Risk Factors and Predictive Score for Bacteremic Biliary Tract Infections Due to Enterococcus faecalis and Enterococcus faecium: a Multicenter Cohort Study from the PROBAC Project. MICROBIOLOGY SPECTRUM
Artículo2022 Seven-versus 14-day course of antibiotics for the treatment of bloodstream infections by Enterobacterales: a randomized, controlled trial CLINICAL MICROBIOLOGY AND INFECTION
Nota2022 Unneeded antibiotics for acute respiratory infections in primary care: stop as early as possible CLINICAL MICROBIOLOGY AND INFECTION
Resumen congreso2021 Antimicrobial stewardship program implementation during the global pandemic of coronavirus disease (COVID-19) INTERNATIONAL JOURNAL OF CLINICAL PHARMACY
Artículo2021 Development and validation of a prediction model for 30-day mortality in hospitalised patients with COVID-19: the COVID-19 SEIMC score THORAX
Artículo2021 Epidemiologic changes in bloodstream infections in Andalucía (Spain) during the last decade CLINICAL MICROBIOLOGY AND INFECTION
Artículo2021 Hospital antibiotic prescribing patterns in adult patients according to the WHO Access, Watch and Reserve classification (AWaRe): results from a worldwide point prevalence survey in 69 countries JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2021 Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study LANCET INFECTIOUS DISEASES
Editorial2021 Preface JAC-antimicrobial resistance
Artículo2021 Repurposed Antiviral Drugs for Covid-19-Interim WHO Solidarity Trial Results NEW ENGLAND JOURNAL OF MEDICINE
Artículo2021 Temocillin versus meropenem for the targeted treatment of bacteraemia due to third-generation cephalosporin-resistant Enterobacterales (ASTARTÉ): protocol for a randomised, pragmatic trial BMJ OPEN
Corrección2020 Author Correction: A nonlinear time-series analysis approach to identify thresholds in associations between population antibiotic use and rates of resistance NATURE MICROBIOLOGY
Artículo2020 Catheter-related bloodstream infections: predictive factors for Gram-negative bacteria aetiology and 30 day mortality in a multicentre prospective cohort JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2020 Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain CLINICAL MICROBIOLOGY AND INFECTION
Artículo2020 Long-term impact of an educational antimicrobial stewardship programme in primary care on infections caused by extended-spectrum β-lactamase-producing Escherichia coli in the community: an interrupted time-series analysis LANCET INFECTIOUS DISEASES
Artículo2020 Pharmacokinetics and safety of aztreonam/avibactam for the treatment of complicated intra-abdominal infections in hospitalized adults: results from the REJUVENATE study JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2020 Quasiexperimental intervention study protocol to optimise the use of new antibiotics in Spain: the NEW_SAFE project BMJ OPEN
Artículo2019 A nonlinear time-series analysis approach to identify thresholds in associations between population antibiotic use and rates of resistance NATURE MICROBIOLOGY
Artículo2019 Executive summary of outpatient parenteral antimicrobial therapy: Guidelines of the Spanish Society of Clinical Microbiology and Infectious Diseases and the Spanish Domiciliary Hospitalisation Society Enfermedades infecciosas y microbiología clínica
Artículo2019 Extended Infusion of β-Lactams for Bloodstream Infection in Patients With Liver Cirrhosis: An Observational Multicenter Study CLINICAL INFECTIOUS DISEASES
Artículo2019 Opportunities for antibiotic optimisation and outcome improvement in patients with negative blood cultures: Study protocol for a cluster-randomised crossover trial, the NO-BACT study BMJ OPEN
Artículo2019 Predictive value of the kinetics of procalcitonin and C-reactive protein for early clinical stability in patients with bloodstream infections due to Gram-negative bacteria DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
Editorial2019 Un paso adelante en la definición de indicadores PROA: medir bien para trabajar mejor FARMACIA HOSPITALARIA
Artículo2018 A prospective multicentre study of the epidemiology and outcomes of bloodstream infection in cirrhotic patients CLINICAL MICROBIOLOGY AND INFECTION
Artículo2018 Análisis de la calidad de uso de antimicrobianos en el servicio de urgencias de un hospital de tercer nivel EMERGENCIAS
Artículo2018 Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey The Lancet Global Health
Artículo2018 Management of bloodstream infections by infection specialists: an international ESCMID cross-sectional survey INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
Capítulo2017 AMS in an Era of Multidrug-Resistant Bacteria ANTIMICROBIAL STEWARDSHIP
Artículo2017 Concordance of Barthel Index, ECOG-PS, and Palliative Performance Scale in the assessment of functional status in patients with advanced medical diseases BMJ SUPPORTIVE & PALLIATIVE CARE
Artículo2017 ESGAP inventory of target indicators assessing antibiotic prescriptions: A cross-sectional survey JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2017 Oral anticoagulation in patients with atrial fibrillation and medical non-neoplastic disease in a terminal stage INTERNAL AND EMERGENCY MEDICINE
Artículo2017 Targeted simplification versus antipseudomonal broad-spectrum beta-lactams in patients with bloodstream infections due to Enterobacteriaceae (SIMPLIFY): a study protocol for a multicentre, open-label, phase III randomised, controlled, non-inferiority clinical trial BMJ OPEN
Artículo2016 A Multinational, Preregistered Cohort Study of beta-Lactam/beta-Lactamase Inhibitor Combinations for Treatment of Bloodstream Infections Due to Extended-Spectrum-beta-Lactamase-Producing Enterobacteriaceae ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Revisión2016 Escherichia coli: an old friend with new tidings FEMS MICROBIOLOGY REVIEWS
Artículo2015 Diagnosis and antimicrobial treatment of invasive infections due to multidrug-resistant Enterobacteriaceae. Guidelines of the Spanish Society of Infectious Diseases and Clinical Microbiology Enfermedades infecciosas y microbiología clínica
Artículo2015 Executive summary of the diagnosis and antimicrobial treatment of invasive infections due to multidrug-resistant Enterobacteriaceae. Guidelines of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) Enfermedades infecciosas y microbiología clínica
Artículo2015 Is reduced vancomycin susceptibility a factor associated with poor prognosis in MSSA bacteraemia? JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2014 Development of a Six-Month Prognostic Index in Patients With Advanced Chronic Medical Conditions: The PALIAR Score JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
Artículo2014 Predictors of early mortality in very elderly patients with bacteremia: a prospective multicenter cohort INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
Artículo2013 Anticoagulación en pacientes pluripatológicos con fibrilación auricular MEDICINA CLINICA
Artículo2013 Evaluating the quality of antimicrobial prescribing: Is standardisation possible? Enfermedades infecciosas y microbiología clínica
Artículo2013 Impact of the MIC of Piperacillin-Tazobactam on the Outcome of Patients with Bacteremia Due to Extended-Spectrum-beta-Lactamase-Producing Escherichia coli ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2013 Reappraisal of the outcome of healthcare-associated and community-acquired bacteramia: a prospective cohort study BMC INFECTIOUS DISEASES
Artículo2013 Recalibración del Palliative Prognostic Index en pacientes con enfermedades médicas avanzadas REVISTA CLINICA ESPANOLA
Artículo2013 Reliability of a short questionnaire for the diagnosis of severe disability in polypathological patients attended in hospital setting EUROPEAN JOURNAL OF INTERNAL MEDICINE
Artículo2012 Impact of Inadequate Empirical Therapy on the Mortality of Patients with Bloodstream Infections: a Propensity Score-Based Analysis ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2012 β-Lactam/β-Lactam Inhibitor Combinations for the Treatment of Bacteremia Due to Extended-Spectrum β-Lactamase-Producing Escherichia coli: A Post Hoc Analysis of Prospective Cohorts CLINICAL INFECTIOUS DISEASES
Artículo2010 Cefalea y visión borrosa en una mujer de 26 años MEDICINA CLINICA
Revisión2010 Current management of bloodstream infections EXPERT REVIEW OF ANTI-INFECTIVE THERAPY
Artículo2010 Epidemiology and clinical features of community-acquired, healthcare-associated and nosocomial bloodstream infections in tertiary-care and community hospitals CLINICAL MICROBIOLOGY AND INFECTION
Resumen congreso2007 Waist to height ratio is linked to insulin resistance ATHEROSCLEROSIS SUPPLEMENTS
ESTUDIO PRONOSTICO DE UNA COHORTE DE BACTERIEMIAS EN FUNCION DE SU ADQUISION: MORBILIDAD, MORTALIDAD Y FACTORES ASOCIADOS (2010)
Dirigida por: Rodriguez Baño, Jesus
Tesis dirigidas/tutorizadas:2
Fecha lectura Título Rol
15/12/2022 Oportunidades para la optimización del tratamiento antibiótico y pronóstico en paciente con hemocultivo negativo (Proyecto NO-BACT)) Director/a
11/10/2022 Programas de optimización de uso de antibióticos (PROA): evaluación de la calidad de uso de antimicrobianos e impacto de la auditoria en dos pasos desde la farmacia hospitalaria Director/a

Proyectos de Investigación

Fecha de inicio Fecha de fin Rol Denominación Agencia financiadora
01/01/2012 31/12/2014 Investigador/a Interacción de mecanismos plasmídicos y cromosómicos de resistencia a quinolonas en escherichia coli y su efecto en la resistencia, fitness, toxicidad celular y expresión en biocapas (PI11/00934) Ministerio de Ciencia e Innovación (Instituto de Carlos III) (Nacional)
El investigador no tiene ningún resultado de investigación asociado